Last Updated 24 September 2021.
This vaccine is approved.
Approved in 71 countries
21 trials in 2 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Approved in 64 countries
11 trials in 4 countries
Approval Source: euractiv.com
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form